Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/15/1991 | EP0427680A1 Heteroatoms-containing tricyclic compounds |
05/15/1991 | EP0427625A1 Internal salts of 2,4-diamino-6-alkoxy-3-sulphooxypyrmidium hydroxide and their use in the treatment and prevention of hair-loss |
05/15/1991 | EP0427606A1 4-Amidino chromane and 4-amidino pyrano(3,2-c)pyridine derivatives, process for preparation and pharmaceutical compositions containing them |
05/15/1991 | EP0427605A1 Morpholine derivatives, process for their preparation and pharmaceutical compositions containing them |
05/15/1991 | EP0427587A1 Process for the preparation of AZT (3'-azido-3'-deoxy-thymidine) and related compounds |
05/15/1991 | EP0427526A1 Pyridine derivatives, processes for their preparation and pharmaceutical compositions thereof |
05/15/1991 | EP0427518A1 NMDA-Blocking compounds, pharmaceutical compositions, their preparation and use |
05/15/1991 | EP0427484A1 Novel benzoxazolone compounds and the use thereof as microbicides |
05/15/1991 | EP0427480A1 2-Hydroxy-3-phenoxypropylamino compounds |
05/15/1991 | EP0427463A1 Substituted N-(imidazolyl)alkyl alanine derivatives |
05/15/1991 | EP0427435A1 Process for direct isolation of captopril |
05/15/1991 | EP0427434A2 11-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha-reductase |
05/15/1991 | EP0427427A2 Use of arylalkylamides in the treatment of neurodegenerative diseases |
05/15/1991 | EP0427402A2 Treatment of shock by cyclodextrins and their derivatives |
05/15/1991 | EP0427390A2 Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them |
05/15/1991 | EP0427248A2 New cephem compounds and processes for preparation thereof |
05/15/1991 | EP0427247A2 Pharmaceutical composition with R-alpha-lipoic acid or S-alpha-lipoic acid as the active ingredient |
05/15/1991 | EP0427246A2 Pharmaceutical compositions comprising sulfur containing carboxylic acids as the active agent as well as their use for combatting retroviruses |
05/15/1991 | EP0427190A2 Polyelectrolyte complexes for the treatment and the prophylaxis of viral diseases and process for their preparation |
05/15/1991 | EP0427161A1 Picolylselenobenzamides of aminopyridines, anilines and picolylamines |
05/15/1991 | EP0427160A1 Benzylselenobenzamides of aminopyridines and picolylamines |
05/15/1991 | EP0427125A1 Benzylseleno-benzamides of anilines and benzylamines |
05/15/1991 | EP0427078A1 Folinic acid-cyclodextrin inclusion compound |
05/15/1991 | EP0427026A2 Compositions for treating fat deposits in humans |
05/15/1991 | EP0426974A2 Composition containing acetaminophen |
05/15/1991 | EP0426824A1 Method for the preparation of active ingredients and pharmaceutical compositions for decorporating radioactive isotopes from living organisms |
05/15/1991 | EP0426816A1 N-PHENYLALKYL SUBSTITUTED $g(a)-AMINO CARBOXAMIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
05/15/1991 | EP0426785A1 Compositions and methods for treating viral infections |
05/15/1991 | EP0426666A1 Substituted quinazolinones as anticancer agents |
05/15/1991 | EP0299963B1 Renin inhibitors having a lactam pseudo dipeptide |
05/15/1991 | EP0298085B1 Ultradense and more soluble and bioavailable preparations of calcium citrate |
05/15/1991 | EP0286643B1 Pharmaceutically active derivatives of glutamic and aspartic acids |
05/15/1991 | EP0282502B1 Imidazole derivatives |
05/15/1991 | EP0270690B1 Drug for treatment and prophylaxis of kidney and liver diseases |
05/15/1991 | EP0261234B1 Dual phase solvent carrier system |
05/15/1991 | EP0259468B1 Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs |
05/15/1991 | EP0163672B1 20-alkyl-7-oxoprostacycline derivatives and production process thereof |
05/15/1991 | CN1051362A Process for preparing omega-phenylamino alkanoic acids substituted on aromatic nucleus by radical derived from 19-nor steroids and their salts |
05/15/1991 | CN1051359A Imidazo (4,5-b) quinolinyloxyalkanoic acid amides with enhanced water solubility |
05/15/1991 | CN1051357A Improved process for useful diazinylpiperides derivatives |
05/15/1991 | CN1051355A Benzimidazole derivatives, their prodn. and use |
05/15/1991 | CN1051354A Substituted cycloalano(b)dihydroindole-and-indolesulphonamides |
05/15/1991 | CN1051299A Methods and compasitions employing certain lysozymes and endoglycosidases |
05/15/1991 | CN1012614B Ceph-3-ene-4-carboxylic acid derivatives and the prepn. |
05/15/1991 | CA2029974A1 Modified gangliosides and the functional derivatives thereof |
05/15/1991 | CA2029771A1 Soluble, non-toxic derivatives of basic polyenic macrolides, their preparation and their applications |
05/14/1991 | WO1991007401A1 3-substituted-1-(aryl or arylalkyl)-2(1h)-quinolinones |
05/14/1991 | WO1991007182A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
05/14/1991 | US5015666 Triarylcyclopropanes as antiestrogens and antitumor agents |
05/14/1991 | US5015664 Orally effective ion chelators related to deferoxamine |
05/14/1991 | US5015663 Treatment of conditions requiring enhanced oxygen availability of mammalian tissues |
05/14/1991 | US5015662 Anthelmintic bioconversion products |
05/14/1991 | US5015661 Chromanes and their pharmaceutical compositions and methods |
05/14/1991 | US5015659 Cognition activators to slow aging of the brain |
05/14/1991 | US5015657 2-halogen-substituted N-indolylethyl-sulphonamides and inhibiting platelet aggregation and antagonizing thromboxane A2 therewith |
05/14/1991 | US5015656 Antidepressants, anxiolytic compounds, central nervous system active compounds for psychotic conditions, aminoalkylcarboxami de derivatives of thiophene |
05/14/1991 | US5015655 1-azabicycloalkane derivatives, their preparation process and their use as medicaments |
05/14/1991 | US5015654 Pharmaceutical compositions |
05/14/1991 | US5015651 Treatment of hypertension with 1,2,4-angiotensin II antagonists |
05/14/1991 | US5015650 Circulation-active basic 4-aryl-DHP amides |
05/14/1991 | US5015648 Use of a thromboxane receptor antagonist in pregnancy-induced hypertension and related conditions |
05/14/1991 | US5015646 Buspirone for treatment of anxiety |
05/14/1991 | US5015645 Cognition activators |
05/14/1991 | US5015644 Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
05/14/1991 | US5015642 Cardiovascular disorders and calcium antagonist |
05/14/1991 | US5015637 Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines |
05/14/1991 | US5015634 Method of treating tissue damage with inositol triphosphate |
05/14/1991 | US5015633 Method for inhibiting loss of cognitive functions employing an ace inhibitor |
05/14/1991 | US5015631 Repair for mucous membranes for nasal obstructions |
05/14/1991 | US5015630 5-oxime avermectin derivatives |
05/14/1991 | US5015578 BMY-41950 antitumor antibiotic |
05/14/1991 | US5015481 Stabilized pharmaceutical admixture composition |
05/14/1991 | US5015479 Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine |
05/14/1991 | US5015478 Porphycene anti-cancer agents and treatment methods |
05/14/1991 | US5015477 Edible, baked compositions containing cholestyramine |
05/14/1991 | US5015463 Porphyrins for fluorescent detection of tumor cells |
05/14/1991 | CA2068514A1 3-substituted-1-(aryl or arylalkyl)-2(1h)-quinolinones |
05/14/1991 | CA2068325A1 Rrna specific oligonucleotides |
05/14/1991 | CA2045143A1 Cephalosporin derivatives |
05/14/1991 | CA2029860A1 Aminomacrolides and derivatives having immuno-suppressive activity |
05/14/1991 | CA2029715A1 Fluoro-naphthacenediones, their glycosilated derivatives and their manufacture procedures |
05/14/1991 | CA2027604A1 N-substituted derivatives of 3r, 4r-ethyl- ((1-methyl-1h-imidazol-5-yl)methyl)-2-pyrrolidinone |
05/14/1991 | CA2027602A1 Pharmaceutical epinephrine-pilocarpine derivatives |
05/14/1991 | CA1284248C Pyrrolidone derivatives |
05/14/1991 | CA1284152C 1'-ethoxycarbonyloxyethyl ester of valproic acid, its preparation and pharmaceutical compositions containing it |
05/14/1991 | CA1284150C (3s,4r)-trans-4-pyrrolidon/piperidon-1-yl-3,4-dihydro-2h- benzo ¬b|pyran-3-olderivatives |
05/14/1991 | CA1284149C Substituted quinoxalinediones and quinolinediones |
05/14/1991 | CA1284147C 7-(substituted) amino-3-substituted cephalosporanic acids and esters |
05/14/1991 | CA1284109C Aqueous solution containing a quinolone carboxylic acid |
05/14/1991 | CA1284108C Hair care compositions |
05/14/1991 | CA1284107C Prazosin-pirbuterol combination for bronchodilation |
05/14/1991 | CA1284106C Pharmaceutical composition for suppressing the immune response |
05/11/1991 | CA2029667A1 Process |
05/11/1991 | CA2029638A1 Cephem compounds and processes for preparation thereof |
05/10/1991 | CA2029581A1 Methods for treatment of alcohol intoxication and dependence |
05/10/1991 | CA2028755A1 Benzoxazolone compounds and the use thereof as microbicides |
05/09/1991 | CA2029601A1 Internal salts of 2,4-diamino-6-alkoxysulfoxy-pyrimidinium and their use in treatments to prevent hair loss |
05/09/1991 | CA2029569A1 Benzoxazine derivatives and pharmaceutical compositions containing the same |
05/08/1991 | WO1991006288A1 A nicotine containing stimulant unit |
05/08/1991 | EP0426656A2 Process for the preparation of 2-arylpropionic acids |